Basilea Pharmaceutica
BSLN.SW
#6003
Rank
โ‚น99.14 B
Marketcap
โ‚น7,999
Share price
-0.28%
Change (1 day)
52.60%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2025: โ‚น385.06

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is โ‚น385.06. In 2025 the company made an earnings per share (EPS) of โ‚น385.06 a decrease over its 2024 EPS that were of โ‚น658.60.

EPS history for Basilea Pharmaceutica from 2002 to 2025

Annual EPS

Year EPS Change
2025โ‚น385.06-41.53%
2024โ‚น658.60586.89%
2023โ‚น95.88-6.28%
2022โ‚น102.31-273.94%
2021-โ‚น58.82-60.87%
2020-โ‚น150.30-24.46%
2019-โ‚น198.97-26.92%
2018-โ‚น272.2559.83%
2017-โ‚น170.34-63.06%
2016-โ‚น461.17-19.26%
2015-โ‚น571.1546.12%
2014-โ‚น390.8710.07%
2013-โ‚น355.10-36.76%
2012-โ‚น561.48-5.42%
2011-โ‚น593.63-153.36%
2010โ‚น1,113-198.47%
2009-โ‚น1,130-15.34%
2008-โ‚น1,33516.7%
2007-โ‚น1,14436.07%
2006-โ‚น840.3679.07%
2005-โ‚น469.28-46.79%
2004-โ‚น881.919.83%
2003-โ‚น802.96-38.94%
2002-โ‚น1,315